Terminated OBSERVATIONAL NCT01357174

ROTATEQ™ Post-Marketing Surveillance in the Philippines

Protocol for ROTATEQ™ Post-Marketing Surveillance

Sponsor: Merck Sharp & Dohme LLC

Conditions Gastroenteritis Rotavirus Infections

Updated 12 times since 2017 Last updated: Oct 29, 2015 Started: Oct 31, 2007 Primary completion: Sep 30, 2010 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Merck Sharp \& Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing surveillance (PMS) study

A observational or N/A phase clinical study on Gastroenteritis and Rotavirus Infections, this trial is terminated or withdrawn. The trial is conducted by Merck Sharp & Dohme LLC and has accumulated 12 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jun 2022 — Jul 2024 [monthly]

Terminated
Dec 2021 — Jun 2022 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated

▶ Show 7 earlier versions

Nov 2020 — Jan 2021 [monthly]

Terminated
Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Terminated NA
Feb 2017 — Aug 2017 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merck Sharp & Dohme LLC

Data source: Merck Sharp & Dohme LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.